ADHD patch safe, effective for teens

11/2/2009 | Forbes

British drugmaker Shire PLC said clinical trial data showed its ADHD patch Daytrana reduced symptoms and was safe in children ages 13 to 17. Daytrana currently is approved for children ages 6 to 12.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT